FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.598
EU - Europa 20.898
AS - Asia 16.621
SA - Sud America 2.290
Continente sconosciuto - Info sul continente non disponibili 468
AF - Africa 424
OC - Oceania 48
Totale 79.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.944
GB - Regno Unito 6.632
IT - Italia 4.916
SG - Singapore 4.612
CN - Cina 4.552
SE - Svezia 3.766
HK - Hong Kong 2.100
BR - Brasile 1.702
VN - Vietnam 1.674
DE - Germania 1.143
TR - Turchia 812
UA - Ucraina 803
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 686
BD - Bangladesh 683
KR - Corea 544
IN - India 412
BG - Bulgaria 314
CA - Canada 309
NL - Olanda 204
AR - Argentina 182
MX - Messico 168
JP - Giappone 162
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 133
ID - Indonesia 131
IE - Irlanda 129
ES - Italia 115
PL - Polonia 110
PK - Pakistan 98
EC - Ecuador 97
BE - Belgio 95
CO - Colombia 91
AE - Emirati Arabi Uniti 88
MY - Malesia 75
CH - Svizzera 66
TH - Thailandia 64
VE - Venezuela 64
CL - Cile 57
MA - Marocco 57
IR - Iran 52
DZ - Algeria 48
LT - Lituania 48
EG - Egitto 46
PH - Filippine 43
UZ - Uzbekistan 42
AU - Australia 40
SA - Arabia Saudita 40
CZ - Repubblica Ceca 37
IL - Israele 37
PT - Portogallo 37
JO - Giordania 36
NP - Nepal 36
PE - Perù 35
TN - Tunisia 34
PY - Paraguay 31
JM - Giamaica 29
AT - Austria 28
KE - Kenya 28
CR - Costa Rica 26
TW - Taiwan 26
AZ - Azerbaigian 25
GR - Grecia 23
EU - Europa 20
KZ - Kazakistan 20
SN - Senegal 19
TT - Trinidad e Tobago 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
BO - Bolivia 16
DK - Danimarca 16
HN - Honduras 15
AL - Albania 14
UY - Uruguay 14
LB - Libano 13
OM - Oman 13
BY - Bielorussia 12
RS - Serbia 12
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
PR - Porto Rico 10
GT - Guatemala 9
KG - Kirghizistan 9
NI - Nicaragua 9
EE - Estonia 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
MN - Mongolia 7
PS - Palestinian Territory 7
SI - Slovenia 7
SV - El Salvador 7
AM - Armenia 6
AO - Angola 6
Totale 78.765
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Ashburn 3.631
Santa Clara 3.470
Singapore 2.890
Fairfield 2.618
Chandler 2.172
Hong Kong 2.062
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.624
San Jose 1.616
Hefei 1.444
Houston 1.329
Chicago 1.281
Dearborn 1.215
Wilmington 1.110
Seattle 1.071
Nyköping 1.060
Ann Arbor 1.050
Council Bluffs 1.015
Beijing 902
Cambridge 889
Los Angeles 834
London 737
Ho Chi Minh City 545
Modena 487
Izmir 465
Seoul 462
Milan 455
Helsinki 441
The Dalles 440
Hanoi 398
New York 398
Salt Lake City 337
Princeton 324
Sofia 301
Eugene 276
Dallas 270
Des Moines 251
Buffalo 248
San Diego 242
Rome 238
Lauterbourg 231
Moscow 182
Redwood City 180
Shanghai 160
Columbus 156
São Paulo 147
Bremen 146
Tampa 144
Elk Grove Village 135
Orem 133
Tokyo 121
Munich 118
Phoenix 111
Dublin 108
Fremont 104
Naples 100
Boardman 98
Bologna 98
Frankfurt am Main 94
Chennai 86
Brussels 82
Lancaster 77
Falls Church 76
Guangzhou 76
Jakarta 70
Da Nang 69
Johannesburg 65
Sterling 65
Atlanta 64
Miami 64
Toronto 63
Haiphong 62
Washington 62
Warsaw 61
Brooklyn 60
Florence 59
Parma 58
Denver 56
Norwalk 54
Montreal 53
Turin 53
Baghdad 50
Bari 49
Como 49
Detroit 48
Nanjing 48
Amsterdam 47
Dulles 47
Mexico City 47
Charlotte 46
Miano 46
Kunming 45
Catania 44
Rio de Janeiro 44
Reggio Emilia 43
Mumbai 41
Belo Horizonte 40
Napoli 39
Totale 54.311
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.340
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 604
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 527
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 523
Cristallinità ed equivalenza nel cloramfenicolo palmitato 503
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 502
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 475
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 470
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 464
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 455
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 444
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 435
NUTRASCIENCE s.r.l. 434
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 428
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 428
Cationic liposomes for gene transfection 427
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 427
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 426
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 420
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 416
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 414
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 412
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 410
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 405
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 404
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 399
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 395
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 390
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 387
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 382
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 382
Polymeric nanoparticles for the drug delivery to the central nervous system 379
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 375
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 375
Nanoparticle transport across the blood brain barrier 375
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 374
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 372
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 371
Distribution of drugs in polymers loaded by swelling 369
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 369
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 369
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 366
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 366
Protein corona and nanoparticles: How can we investigate on? 364
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 355
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 355
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 354
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 353
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 351
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 350
Microwave-treated gelatin microspheres as drug delivery system 349
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 344
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 344
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 342
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 341
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 341
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 339
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 339
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 339
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 338
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 338
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 336
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 335
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 335
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 331
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 330
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 330
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 330
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 329
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 329
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 329
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 328
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 328
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 328
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 327
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 326
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 326
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 322
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 322
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 320
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 317
Functionalization of liposomes: microscopical methods for preformulative screening 314
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 314
Colloidal systems for CNS drug delivery 311
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 311
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 310
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 306
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 305
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 304
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 302
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 302
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 301
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 299
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 297
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 296
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 294
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 293
Totale 38.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 285.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 285.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.423 0 0 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202624.442 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 2.108 1.245 991
2026/20272.516 523 1.426 567 0 0 0 0 0 0 0 0 0
Totale 79.347